Inquiry Basket
Loading ......
Filter By Product Search for
AATK
AATK Full Name
apoptosis-associated tyrosine kinase
AATK Introduction
Apoptosis-associated tyrosine kinase (AATK), also widely classified in scientific literature as lemur tyrosine kinase 1 (LMTK1) or AATYK, is a fascinating brain-enriched kinase. Despite its historical nomenclature suggesting it is a tyrosine kinase, comprehensive structural and biochemical analyses have revealed that AATK primarily functions as a serine/threonine-protein kinase. The protein is characterized by an N-terminal kinase domain and a prolonged C-terminal proline-rich region, existing in multiple splice variants, including both membrane-anchored and cytosolic forms. Initially identified for its dramatic upregulation during the apoptosis of myeloid precursor cells, AATK is predominantly expressed in the central nervous system, where it plays a multifaceted role in cellular fate, survival, and structural development.
Figure 1. Domain structure of the two isoforms of mouse lemur tail (former tyrosine) kinase 1 (LMTK1) and human LMTK1-3. (Source: Hisanaga SI, et al. 2020)
AATK is heavily involved in both neurodevelopment and the complex regulation of programmed cell death. In the developing nervous system, AATK actively promotes neuronal differentiation, neurite extension, and dendritic arborization. It regulates these processes largely by localizing to intracellular membranes, such as early and recycling endosomes, where it modulates crucial vesicle trafficking pathways—including the Rab11A-dependent trafficking of key receptors and enzymes. Beyond its direct enzymatic activity, AATK operates as a vital scaffolding molecule; for instance, it recruits protein phosphatase 1 (PP1) and SPAK to regulate the activity of the NKCC1 ion cotransporter. Furthermore, depending on the specific cellular context and extracellular stimuli, AATK acts as a molecular switch, coordinating signaling cascades that dictate whether a cell survives, differentiates, or ultimately undergoes apoptosis.
Clinically, the dysregulation of AATK is prominently linked to both neurological pathologies and severe malignancies. Because of its active role in endosomal trafficking, AATK is known to regulate the subcellular localization of BACE1, a critical enzyme in Alzheimer's disease pathogenesis, pointing to its involvement in neurodegeneration. In the field of oncology, AATK predominantly functions as a potent tumor suppressor. It is frequently epigenetically silenced via DNA hypermethylation in a wide array of human cancers, including pancreatic adenocarcinoma, lung cancer, and melanoma. The loss of AATK expression removes its inhibitory constraints on cell cycle progression, significantly facilitating unchecked tumor cell proliferation, migration, and resistance to radio- and chemotherapies. Consequently, restoring AATK function or targeting its downstream pathways represents an active area of therapeutic research.
Alternate Names for AATK
AATK; apoptosis-associated tyrosine kinase; serine/threonine-protein kinase LMTK1; AATYK; AATYK1; KIAA0641; lemur tyrosine kinase 1; LMR1; LMTK1; p35-binding protein; CDK5-binding protein; brain apoptosis-associated tyrosine kinase; p35BP;
Loading ......
